Danielle Feigenbaum

Danielle Feigenbaum, MD is a Clinical Associate Professor (Part-Time) of Neurology at the University of Southern California. Her clinical expertise focuses on movement disorders such as Parkinson’s disease, dystonia, ataxia, and chorea. She actively leads clinical trials for Parkinson’s and dystonia treatments while researching biomarkers for Parkinson’s diagnosis.

Her research emphasizes tear-based biomarkers and the role of physical activity in neurological health. Dr. Feigenbaum has contributed to studies on subthalamic nucleus stimulation effects, alpha-synuclein biomarkers, and statin mechanisms in CNS disorders. She has published in journals like Brain Stimul and Biomark Med.

Her work bridges clinical practice with translational research, aiming to improve diagnostic tools and treatment strategies for neurodegenerative diseases. No specific awards or grants are listed, but her involvement in multiple clinical trials demonstrates active engagement in therapeutic development.